The Kidney Care Council Overview, ESRD Prospective Payment System (PPS), ESRD PPS: From ATRA to PAMA and the Impact of Medicare on Healthcare Professionals, Protecting Bundle Integrity, Increased Scrutiny on Dialysis Cost Reports, Sustainable Growth Rate, Federal Funding for Research, Fewer Clinical Trials and New Therapies in Kidney Than Other Diseases, Quality Programs and Delivery of Care, Integrated Care, ESRD Seamless Care Organizations (ESCO), Comprehensive ESRD Care Initiative (CEC),...

Healthcare in America: Impact of the Economy on Healthcare, Medicare Payment Changes Already in Law, New Sources of Authority to Reduce Spending, the Environment and Healthcare: the Affordable Care Act and Insurance, The Paths Forward: A Two-Tiered Healthcare System, Changes in the Delivery System, Patient Participation in Their Own Healthcare.

ASN's Perspective on Nephrologists and the Current Environment in Kidney Care, Government Impact on Patient Care, Research and Education, Globalization Changing Healthcare, Awareness of Kidney Disease, Kidney Care in the Future: Bright or Dreary? Top 10 Reasons Why U.S. Medical Students are Not Choosing Nephrology Careers, Defining the Future Nephrologist, Fostering Innovation and Improvement in Kidney Care.

Changing Models of Kidney Care, Nursing Expertise Standards: Comprehensive Assessment, Delivery and Coordination of Care, Patient Centered Care, Providing Encouragement and Support, Providing Education; and Barriers to Maximizing Nurse Engagement.

Panel Discussion and Q&A: New Models for the Delivery of Kidney Care. How We Define the Quality of Care and the Debate on When to Start Dialysis, the FDA and Kidney Care, Reimbursement, and the Reduction of U.S. Medical Students Specializing in Nephrology.

Ms. Nancy Scott's Story and Experience Living With Kidney Disease. Patients as Part of the Solution and as an Advocate for Their Own Healthcare, Dialysis Patients Citizens.

Introduction of New Models for the Delivery of Care. Distribution of General Medicare Patients and Costs and Expenditures for Chronic Kidney Disease, Congestive Heart Failure, Diabetes, and ESRD; Kidney Disease as a Continuum; Renal Disease as the Prime Model for the Prevention and Management of Chronic Illness

Welcome and Introductions